Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Pemetrexed and Cisplatin or Carboplatin in Combination With TTFields (150 kHz) as First-line Treatment in Malignant Pleural Mesothelioma

NCT02397928 is registered in ClinicalTrials.gov with NovoCure Ltd. as lead sponsor.

NCT NCT02397928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02397928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Pemetrexed and Cisplatin or Carboplatin in Combination With TTFields (150 kHz) as First-line Treatment in Malignant Pleural Mesothelioma
Lead sponsor
NovoCure Ltd.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2015
Completion date
April 30, 2018
Enrollment
82 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural mesothelioma